→Appendix 1: bedaquiline
PDF page 640
▶Common or very common Arthralgia. diarrhoea. dizziness.
headache. hepatic function abnormal. myalgia. nausea.
QT interval prolongation. vomiting
SIDE-EFFECTS, FURTHER INFORMATION If syncope occurs,
obtain ECG.
PDF page 640
Manufacturer advises avoid unless potential
benefit outweighs risk.
PDF page 640
Manufacturer advises avoid—present in
milk in animal studies.
PDF page 640
Manufacturer advises caution in
moderate impairment; avoid in severe impairment—no
information available.
PDF page 640
Manufacturer advises caution if eGFR
less than 30 mL/minute/1.73 m2.
PDF page 640
▶Determine serum potassium, calcium, and magnesium
before starting treatment (correct if abnormal)—
remeasure if QT prolongation occurs during treatment.
▶Obtain ECG before starting treatment, and then at least
monthly during treatment or more frequently if
concomitant use with other drugs known to prolong the
QT interval.
▶Monitor liver function before starting treatment and then
at least monthly during treatment—discontinue treatment
if severe abnormalities in liver function tests.
PDF page 641